Therapeutics Acquisition Corp. (RACA)
|Net Income (ttm)||n/a|
|Trading Day||January 15|
|Day's Range||13.82 - 14.13|
|52-Week Range||12.02 - 15.85|
These shell companies allow the businesses they acquire to go public much more quickly than an IPO would. Is it time to buy in?
Forget traditional IPOs! This blank check vehicle is proving to be an effective tool for biotech companies to raise capital.
BOSTON--(BUSINESS WIRE)--Therapeutics Acquisition Corp. (Nasdaq: TXAC) (the "Company") announced today that on July 10, 2020 it closed its initial public offering of 13,570,000 shares ...
The special purpose acquisition company is sponsored by RA Capital Management.
Therapeutics Acquisition, doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.
|IPO Date |
Jul 8, 2020
Dr. Peter Kolchinsky Ph.D.
|Stock Exchange |
|Ticker Symbol |